Article Text

Download PDFPDF

LP-070 Medication compliance in systemic lupus erythematosus: community-based study in Surakarta, Indonesia
  1. Indrayana Sunarso1,
  2. Ariana Setiani2,
  3. Arief Nurudhin1 and
  4. Yuyani Werdiningsih1
  1. 1Rheumatology Division Internal Medicine, Faculty of Medicine Sebelas Maret University, Indonesia
  2. 2Psychiatry Department, Faculty of Medicine Sebelas Maret University, Indonesia


Background Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease requiring a long-term therapeutic approach. Low compliance with medication leads to the worsening of the disease. Evaluating medication compliance rates and factors associated with low compliance are important to design further compliance interventions.

Methods We conducted a cross-sectional analysis of adult individuals with SLE from Tittari Community, Surakarta. Patient completed the 5-item version of Compliance Questionnaire for Rheumatology (CQR5), Quick Systemic Lupus Activity questionnaire (Q-SLAQ), and Hamilton Anxiety Depression Rating Scale (HADS). Association between compliance and demographic, disease-related characteristics, and medication characteristics were explored.

Results A total of 78 individuals with SLE participated in the study, 76 (96.4%) were female with a mean age of 36±10.9 years. The Majority of SLE patients reported disease duration >5 years (52.7%), were prescribed <5 drugs (52.7%) and had side effect complaints in 28 (35.89%). Low compliance was found in 29.49% of patients. In logistic regression analysis, having mental health issues such as anxiety (OR 4.3, CI 95% 0.6–28.7), depression (OR 3.7, CI 95% 0.9–14.1), or both anxiety and depression (OR 2.6, CI 95% 0.5–13.5) tend to increase the risk of low compliance. Other factors associated with low compliance were disease duration of 1–3 years (OR 4.9, CI 95% 0.5–47.7), and the presence of medication adverse events (OR 1.7, CI 95% 0.6–5.1).

Conclusions The prevalence of low medication compliance among SLE patients was high. SLE patients with anxiety and/or depression who had been living with the disease for 1–3 years, or experienced medication adverse events were found to have a higher risk of low compliance.

  • systemic lupus erythematosus
  • medication compliance

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.